Interim analysis in clinical trials

Fertility and Sterility

Volumn 97, Issue 3, 2012, Pages

  Su, Hui Chun Irene ^a   Sammel, Mary D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN;

CLINICAL TRIAL (TOPIC); FALSE POSITIVE RESULT; FERTILIZATION IN VITRO; HEALTH CARE PERSONNEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LETTER; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TISSUE CULTURE; TREATMENT PLANNING;

CHORIONIC GONADOTROPIN; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; PREGNANCY; PREGNANCY RATE;

EID: 84857789762     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.01.107     Document Type: Letter

References (3)

1. R. Mansour, N. Tawab, O. Kamal, Y. El-Faissal, A. Serour, and M. Aboulghar Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study Fertil Steril 96 2011 1370 1374
2. K.F. Schulz, and D.A. Grimes Multiplicity in randomised trials II: subgroup and interim analyses Lancet 365 2005 1657 1661
3. S.J. Pocock When (not) to stop a clinical trial for benefit JAMA 294 2005 2228 2230